摘要
目的:探讨氯胺酮依赖患者的汉密尔顿抑郁量表-17(HAMD-17)因子结构维度,并与单、双相抑郁症患者进行比较。方法:共入组342例氯胺酮依赖患者和131例单、双相抑郁患者(包括70例单相抑郁患者和61例双相抑郁发作患者),采用HAMD-17量表评估其抑郁症状。应用主成分因子分析法分析两组患者HAMD-17量表的因子结构特点和异同。结果:氯胺酮依赖患者组HAMD-17总分显著低于单、双相抑郁患者组,差异有统计学意义(P<0.05),HAMD-17量表中的各个条目在两组患者间的得分趋势较相似。主成分因子分析显示,氯胺酮依赖患者组HAMD-17量表呈4因子结构(躯体化焦虑、抑郁、睡眠障碍和因子4),其解释的变异性百分比为54.5%;单、双相抑郁患者组则呈5因子结构(躯体化焦虑、抑郁、睡眠障碍、因子4和因子5),其解释的变异性百分比为61.5%。躯体化焦虑因子、抑郁因子和睡眠障碍因子是两组患者抑郁症状的主要因子。结论:本研究结果初步揭示了HAMD-17量表在氯胺酮依赖患者和单、双相抑郁症患者中的因子结构的异同点。
Objective:To explore the factor structure dimensions of HAMD-17 in ketamine dependent patients,and compare with dimensions from unipolar and bipolar depressive patients.Methods:The depressive symptoms of 342 ketamine dependent patients,131 patients with unipolar depressive or bipolar disorder(BD)were evaluated by the HAMD-17.The factor structures of the HAMD-17 in the two groups were determined by principal component factor analysis with varimax rotation.Results:The total score of HAMD-17 in ketamine dependent patients was significantly lower than that in unipolar and bipolar depression patients(P<0.05).The scores of each item in HAMD-17 scale were similar between the two groups.Principal component factor analysis showed that the HAMD-17 scale of ketamine dependent patients had a four-factor structure(somatization anxiety,depression,sleep disorders and factor 4),which explained 54.5%of the variability.The patients with unipolar and bipolar depression showed a fivefactor structure(somatization anxiety,depression,sleep disorders,factor 4 and factor 5),which explained 61.5%of the variability.Somatization anxiety factor,depression factor and sleep disorder factor were the main factors of depressive symptoms in the two groups.Conclusion:Our results could provide some degrees of insight into the similarities and differences in the factor structure of the depressive symptoms for these two groups.
作者
张敏玲
麦思茗
何红波
宁玉萍
丁毅
柯晓殷
范妮
ZHANG Minling;MAI Simig;HE Hongbo;NING Yuping;ING Yi;KE Xiaoyin;FAN Ni(Neuropsychiatric Research Institute of the Affiliated Brain Hospital,Guangzhou Medical University,Guangzhou 510370,Guangdong,China;Children Psychiatric Department of the Affiliated Brain Hospital,Guangzhou Medical University,Guangzhou 510370,Guangdong,China;Substance Dependence Department of the Affliated Brain Hospital,Guangzhou Medical University,Guangzhou 510370,Guangdong,China;Teaching Ofice of Shenzhen Kangning Hospital,Shenzhen 518118,Guangdong,China;Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China,Guangzhou Medical University,Guangzhou 510370,Guangdong,China)
出处
《中国药物滥用防治杂志》
CAS
2024年第10期1785-1789,共5页
Chinese Journal of Drug Abuse Prevention and Treatment
基金
广州市医学重点学科(编号:2021-2023)
广东省自然科学基金项目(编号:2020A1515011173)
广东省科技计划项目(编号:2019B030316001)
广州市研究型医院(编号:无)。
关键词
汉密尔顿抑郁量表
抑郁症状
因子分析
氯胺酮
Hamilton depression scale
Depressive symptom
Factor analysis
Ketamine